The intricate molecular processes underlying Gαq‐driven carcinogenic signaling are highlighted by the propensity of Q209 and R183 Gαq hotspot mutations to occur in solid tumors, compared with the prevalence of Y101 and T96 in hematological cancers. This evidence concerns the gene GNAQ and hematopoietic and lymphoid cell neoplasm.